Investor Alert




Market closed

 --Quotes are delayed by 20 min

Sep 23, 2022, 3:16 p.m.





-2.64 -3.47%


Volume 2,774

Quotes are delayed by 20 min


Previous close

$ 76.00

$ 73.36


-2.64 -3.47%

Day low

Day high




52 week low

52 week high




Paul Hudson

Mr. Paul Hudson is a Chief Executive Officer & Director at Sanofi, a Chairman at Novartis Pharma KK and a Chief Executive Officer & Director at Sanofi Clir SENC. He is on the Board of Directors at Sanofi and Sanofi Clir SENC. Mr. Hudson was previously employed as a Chief Executive Officer by Novartis Pharmaceuticals Corp., a President-AstraZeneca US & EVP-North America by AstraZeneca Plc, a President by AstraZéneca Farmacéutica Spain SA, a President & Director by AstraZeneca KK, a Member-Executive Committee by Novartis AG, and a Head-Global Marketing by Schering Plough Holdings France SAS. He received his undergraduate degree from Manchester Metropolitan University of.


Date Shares Transaction Value
12/13/2019 5,600   Acquisition at $88.51 per share. 495,656
12/13/2019 5,600   Acquisition at $88.51 per share. 495,656

Officers and Executives

Mr. Serge Weinberg
Mr. Paul Hudson
Chief Executive Officer & Director
Mr. Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer & Executive Vice President
Dr. Dietmar P. Berger
Chief Medical Officer & Global Head-Development
Dr. John C. Reed
EVP & Global Head-Research & Development
Dr. Nestle Frank
Global Head-Immunology Therapeutic Research Area
Dr. Arnaud Robert
Chief Digital Officer & Executive Vice President
Ms. Julie van Ongevalle
Executive VP & Head-Consumer Healthcare
Mr. William J. Sibold
Executive Vice President-Sanofi Genzyme
Ms. Alexandra Roger
Head-Securities Law & Capital Markets
Mr. Brendan OCallaghan
Executive Vice President & Head-Industrial Affairs
Mr. Josep Catlla
Mr. Raj Verma
Chief Diversity, Culture & Experience Officer
Ms. Noel M. Geoffroy
Head-North America Consumer Healthcare
Mr. Olivier Antoine M. Charmeil
Executive Vice President-General Medicines
Mr. Yann Tran
Dr. Wolfgang Laux
Mr. Frédéric Oudéa
Mr. Christophe Babule
Ms. Eva Schäfer-Jansen
Investor Relations Contact
Ms. Natalie Bickford
Chief People Officer & Executive Vice President
Ms. Claire Terrazas
Vice President-Corporate Legal Affairs
Mr. Roy Papatheodorou
General Counsel
Mr. Arnaud Delépine
Investor Relations Officer
Ms. Rachel Duan
Independent Non-Executive Director
Ms. Lise Kingo
Independent Director
Mr. Gilles Schnepp
Independent Director
Ms. Barbara Lavernos
Independent Director
Ms. Carole Gabriella Ferrand
Independent Director
Dr. Emile Voest
Independent Director
Dr. Antoine Yver
Independent Director
Ms. Fabienne Lecorvaisier
Independent Director
Mr. Patrick Kron
Independent Director
Ms. Diane D. Souza
Independent Director
Dr. Thomas C. Südhof
Independent Director
Link to MarketWatch's Slice.